Tenax Therapeutics Inc
NASDAQ:TENX 3:58:05 PM EDT
Products, Regulatory
Tenax Announces Successful Comparative Pharmacokinetic Study Of Pulmonary Arterial Hypertension Treatment
Published: 05/23/2022 13:18 GMT
Tenax Therapeutics Inc (TENX) - Tenax Therapeutics Announces Successful Comparative Pharmacokinetic Study of Tnx-201 for the Treatment of Pulmonary Arterial Hypertension.
Tenax Therapeutics Inc - Manufacturing Underway to Support Phase 3 Pah Study (improve).
Tenax Therapeutics Inc - Clinical Sites Are Now Being Recruited, With Patient Enrolment Expected to Start in 2h 2022.
Tenax Therapeutics Inc - Manufacturing Underway to Support Phase 3 Pah Study (improve).
Tenax Therapeutics Inc - Clinical Sites Are Now Being Recruited, With Patient Enrolment Expected to Start in 2h 2022.